<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:8e08bf35-5020-4e75-b768-4ff0d991ccc9,g:4c918b94-6522-4c97-a574-9f034eaff87f-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.pharming.com/role/StatementofcomprehensiveincomeprofitorlossbyfunctionofexpenseStatement" xlink:type="simple" xlink:href="pharm-2024-12-31.xsd#StatementofcomprehensiveincomeprofitorlossbyfunctionofexpenseStatement"/>
  <link:calculationLink xlink:role="http://www.pharming.com/role/StatementofcomprehensiveincomeprofitorlossbyfunctionofexpenseStatement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_ac29b46e-c465-40a3-bed1-c5eb28228dc3" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_c0e3fb8e-5322-40de-b678-5f5c743b31e2" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_ac29b46e-c465-40a3-bed1-c5eb28228dc3" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_c0e3fb8e-5322-40de-b678-5f5c743b31e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncomeCost_c413d825-c6fe-45ec-bf86-689d2c26a4e3" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_FinanceIncomeCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_ac29b46e-c465-40a3-bed1-c5eb28228dc3" xlink:to="loc_ifrs-full_FinanceIncomeCost_c413d825-c6fe-45ec-bf86-689d2c26a4e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_d903632d-0eef-40a8-acdf-2e8de7ca6ccc" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_ac29b46e-c465-40a3-bed1-c5eb28228dc3" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_d903632d-0eef-40a8-acdf-2e8de7ca6ccc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherExpenseByFunction_df2d2379-7c2e-4a87-be83-1407b0b76846" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherExpenseByFunction"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_f2d5c85c-4c81-4c46-9ef2-17c7860fa3bc" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SalesAndMarketingExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherExpenseByFunction_df2d2379-7c2e-4a87-be83-1407b0b76846" xlink:to="loc_ifrs-full_SalesAndMarketingExpense_f2d5c85c-4c81-4c46-9ef2-17c7860fa3bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdministrativeExpense_b466b18c-c26c-4385-a866-822c6b4ffbb2" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherExpenseByFunction_df2d2379-7c2e-4a87-be83-1407b0b76846" xlink:to="loc_ifrs-full_AdministrativeExpense_b466b18c-c26c-4385-a866-822c6b4ffbb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_d52a30fd-c80b-428b-b819-95933436fc6e" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherExpenseByFunction_df2d2379-7c2e-4a87-be83-1407b0b76846" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_d52a30fd-c80b-428b-b819-95933436fc6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_d9bda2df-6130-4f94-a3b4-3cadebd05494" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherIncome_f1afaae9-ac4a-4a1b-913b-e53781cdabf3" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_d9bda2df-6130-4f94-a3b4-3cadebd05494" xlink:to="loc_ifrs-full_OtherIncome_f1afaae9-ac4a-4a1b-913b-e53781cdabf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossProfit_528bc230-9be5-4492-b67c-7854c8e1a14f" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GrossProfit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_d9bda2df-6130-4f94-a3b4-3cadebd05494" xlink:to="loc_ifrs-full_GrossProfit_528bc230-9be5-4492-b67c-7854c8e1a14f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherExpenseByFunction_edb3d203-6c64-412e-9146-97eff3a78f5f" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherExpenseByFunction"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_d9bda2df-6130-4f94-a3b4-3cadebd05494" xlink:to="loc_ifrs-full_OtherExpenseByFunction_edb3d203-6c64-412e-9146-97eff3a78f5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncomeCost_df8dc7d0-b856-483b-aa28-9c34d570d561" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_FinanceIncomeCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceIncome_bce4d327-2ede-4225-9adb-82223a2c579f" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_FinanceIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncomeCost_df8dc7d0-b856-483b-aa28-9c34d570d561" xlink:to="loc_ifrs-full_FinanceIncome_bce4d327-2ede-4225-9adb-82223a2c579f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinanceCosts_c0c90eb3-7a4b-48fa-9437-0194383ccc10" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_FinanceCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncomeCost_df8dc7d0-b856-483b-aa28-9c34d570d561" xlink:to="loc_ifrs-full_FinanceCosts_c0c90eb3-7a4b-48fa-9437-0194383ccc10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss_19ee4e3b-17c7-478a-bb05-a1be0f2332da" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncomeCost_df8dc7d0-b856-483b-aa28-9c34d570d561" xlink:to="loc_ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss_19ee4e3b-17c7-478a-bb05-a1be0f2332da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossProfit_73959054-064f-4cbd-ae4b-79f1ff362330" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Revenue_5bfdff2c-8c45-44e4-b261-99ec0b41de74" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Revenue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GrossProfit_73959054-064f-4cbd-ae4b-79f1ff362330" xlink:to="loc_ifrs-full_Revenue_5bfdff2c-8c45-44e4-b261-99ec0b41de74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSales_7d1de5fc-784f-4223-8b71-366b752d8442" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CostOfSales"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GrossProfit_73959054-064f-4cbd-ae4b-79f1ff362330" xlink:to="loc_ifrs-full_CostOfSales_7d1de5fc-784f-4223-8b71-366b752d8442" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_a3ed294a-266e-45cb-b0d5-63b43181fd3f" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_7d9a252f-4270-4175-9913-b7a564a451e4" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_a3ed294a-266e-45cb-b0d5-63b43181fd3f" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_7d9a252f-4270-4175-9913-b7a564a451e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_de793ea6-faa4-4ef4-8c72-2a5334748bf0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_a3ed294a-266e-45cb-b0d5-63b43181fd3f" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_de793ea6-faa4-4ef4-8c72-2a5334748bf0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pharming.com/role/StatementofcomprehensiveincomeOCIcomponentspresentednetoftaxStatement" xlink:type="simple" xlink:href="pharm-2024-12-31.xsd#StatementofcomprehensiveincomeOCIcomponentspresentednetoftaxStatement"/>
  <link:calculationLink xlink:role="http://www.pharming.com/role/StatementofcomprehensiveincomeOCIcomponentspresentednetoftaxStatement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_978ade83-270d-4dbb-9909-8508283c6c8b" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments_a3835902-89c6-4f9a-a7e2-547b7e4a6908" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_978ade83-270d-4dbb-9909-8508283c6c8b" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesFromInvestmentsInEquityInstruments_a3835902-89c6-4f9a-a7e2-547b7e4a6908" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_70017b60-a0a7-4d91-ae65-6c02b3081bad" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_da8ac8dd-6bb3-4db5-b215-f9856c51a47a" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_70017b60-a0a7-4d91-ae65-6c02b3081bad" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_da8ac8dd-6bb3-4db5-b215-f9856c51a47a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_4ecdfef2-42d1-49be-8bc0-0f5dc3334c1e" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_0ea93704-b1cb-4705-8136-befb4360c30f" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncome_4ecdfef2-42d1-49be-8bc0-0f5dc3334c1e" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_0ea93704-b1cb-4705-8136-befb4360c30f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_d96a75da-b6a3-40cc-95cb-59aba5951849" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncome_4ecdfef2-42d1-49be-8bc0-0f5dc3334c1e" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_d96a75da-b6a3-40cc-95cb-59aba5951849" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pharming.com/role/StatementoffinancialpositioncurrentnoncurrentStatement" xlink:type="simple" xlink:href="pharm-2024-12-31.xsd#StatementoffinancialpositioncurrentnoncurrentStatement"/>
  <link:calculationLink xlink:role="http://www.pharming.com/role/StatementoffinancialpositioncurrentnoncurrentStatement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAndLiabilities_eb3ab3e8-2330-47b7-9554-1dd0f8524006" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityAndLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_ebfb83e1-547b-43d9-85ae-30de75f9d00c" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Equity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities_eb3ab3e8-2330-47b7-9554-1dd0f8524006" xlink:to="loc_ifrs-full_Equity_ebfb83e1-547b-43d9-85ae-30de75f9d00c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilities_971442ab-5820-470b-8ff1-cc2ef4c961b0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities_eb3ab3e8-2330-47b7-9554-1dd0f8524006" xlink:to="loc_ifrs-full_CurrentLiabilities_971442ab-5820-470b-8ff1-cc2ef4c961b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilities_2d449c8c-e4c2-4066-b0db-167d45355f90" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities_eb3ab3e8-2330-47b7-9554-1dd0f8524006" xlink:to="loc_ifrs-full_NoncurrentLiabilities_2d449c8c-e4c2-4066-b0db-167d45355f90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssets_d3d739ab-06d6-457b-a07e-07877ab2e474" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_7fbd960c-40a4-4dea-a31c-8514b1fe023d" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_d3d739ab-06d6-457b-a07e-07877ab2e474" xlink:to="loc_ifrs-full_CashAndCashEquivalents_7fbd960c-40a4-4dea-a31c-8514b1fe023d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_09a74f75-12e4-4e72-bc30-6cfb6ec09f4b" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_d3d739ab-06d6-457b-a07e-07877ab2e474" xlink:to="loc_ifrs-full_TradeAndOtherCurrentReceivables_09a74f75-12e4-4e72-bc30-6cfb6ec09f4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Inventories_f9697806-7853-44f1-92d0-602db5023c95" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Inventories"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_d3d739ab-06d6-457b-a07e-07877ab2e474" xlink:to="loc_ifrs-full_Inventories_f9697806-7853-44f1-92d0-602db5023c95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pharm_MarketableSecurities_4a01f557-7b3e-4cb9-b98c-130e9f0f13c3" xlink:href="pharm-2024-12-31.xsd#pharm_MarketableSecurities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_d3d739ab-06d6-457b-a07e-07877ab2e474" xlink:to="loc_pharm_MarketableSecurities_4a01f557-7b3e-4cb9-b98c-130e9f0f13c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilities_088a9e2d-ce54-4262-8ddb-be9b4de0eb44" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayables_878e4fb2-c04e-403c-859a-b7c349daa57b" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayables"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_088a9e2d-ce54-4262-8ddb-be9b4de0eb44" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayables_878e4fb2-c04e-403c-859a-b7c349daa57b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentBondsIssuedAndCurrentPortionOfNoncurrentBondsIssued_69154dd9-af50-4493-a50d-55ec3a4b44eb" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentBondsIssuedAndCurrentPortionOfNoncurrentBondsIssued"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_088a9e2d-ce54-4262-8ddb-be9b4de0eb44" xlink:to="loc_ifrs-full_CurrentBondsIssuedAndCurrentPortionOfNoncurrentBondsIssued_69154dd9-af50-4493-a50d-55ec3a4b44eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_227715ce-6305-4073-91e2-28ac1d31fbde" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_088a9e2d-ce54-4262-8ddb-be9b4de0eb44" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_227715ce-6305-4073-91e2-28ac1d31fbde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Assets_4955e91a-7f4d-4634-af6e-841b1fb41998" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssets_61369a7e-c66a-4e3c-b3e7-b1e3b8a8f710" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_4955e91a-7f4d-4634-af6e-841b1fb41998" xlink:to="loc_ifrs-full_NoncurrentAssets_61369a7e-c66a-4e3c-b3e7-b1e3b8a8f710" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssets_732a21e1-82d7-4334-8de6-9ea77c884cf2" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_4955e91a-7f4d-4634-af6e-841b1fb41998" xlink:to="loc_ifrs-full_CurrentAssets_732a21e1-82d7-4334-8de6-9ea77c884cf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssets_8c6e3514-2112-44e6-b2d6-3ef3908587b7" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_373705c3-2147-48a8-9e0f-e0b63d1a9c18" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_8c6e3514-2112-44e6-b2d6-3ef3908587b7" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_373705c3-2147-48a8-9e0f-e0b63d1a9c18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssets_83644063-3c6d-4d2a-9724-fd476212a7e0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RightofuseAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_8c6e3514-2112-44e6-b2d6-3ef3908587b7" xlink:to="loc_ifrs-full_RightofuseAssets_83644063-3c6d-4d2a-9724-fd476212a7e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentRestrictedCashAndCashEquivalents_e6eb0f95-b1a5-4290-906b-22ccd3455389" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentRestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_8c6e3514-2112-44e6-b2d6-3ef3908587b7" xlink:to="loc_ifrs-full_NoncurrentRestrictedCashAndCashEquivalents_e6eb0f95-b1a5-4290-906b-22ccd3455389" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_6391b755-47b8-4163-9184-ec955279dc69" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_8c6e3514-2112-44e6-b2d6-3ef3908587b7" xlink:to="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_6391b755-47b8-4163-9184-ec955279dc69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxAssets_fffccd82-3102-4e3e-a515-e538c8b0fb29" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DeferredTaxAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_8c6e3514-2112-44e6-b2d6-3ef3908587b7" xlink:to="loc_ifrs-full_DeferredTaxAssets_fffccd82-3102-4e3e-a515-e538c8b0fb29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentInvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncome_1ef5ad63-13e0-41df-9c20-7007e6a111a6" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentInvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncome"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_8c6e3514-2112-44e6-b2d6-3ef3908587b7" xlink:to="loc_ifrs-full_NoncurrentInvestmentsInEquityInstrumentsDesignatedAtFairValueThroughOtherComprehensiveIncome_1ef5ad63-13e0-41df-9c20-7007e6a111a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_0a51721f-ae98-4a32-a126-a8f2044ae7a6" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_8c6e3514-2112-44e6-b2d6-3ef3908587b7" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_0a51721f-ae98-4a32-a126-a8f2044ae7a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentPrepayments_f1bcce03-bf92-49ee-996d-2b6395e757f8" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentPrepayments"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_8c6e3514-2112-44e6-b2d6-3ef3908587b7" xlink:to="loc_ifrs-full_NoncurrentPrepayments_f1bcce03-bf92-49ee-996d-2b6395e757f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss_42ae2cc5-03d6-4f89-b664-3f52cb57e95b" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_8c6e3514-2112-44e6-b2d6-3ef3908587b7" xlink:to="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughProfitOrLoss_42ae2cc5-03d6-4f89-b664-3f52cb57e95b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_a80581da-e0cf-44b9-a6a9-b940332cd795" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Equity"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherReserves_c4eb3695-c864-4f56-afa9-2d3138ae6d63" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_a80581da-e0cf-44b9-a6a9-b940332cd795" xlink:to="loc_ifrs-full_OtherReserves_c4eb3695-c864-4f56-afa9-2d3138ae6d63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremium_06354855-3421-42dc-ae9e-54fb330d3282" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SharePremium"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_a80581da-e0cf-44b9-a6a9-b940332cd795" xlink:to="loc_ifrs-full_SharePremium_06354855-3421-42dc-ae9e-54fb330d3282" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarnings_d273e5da-9a8b-4e15-b021-61f662ed2ba6" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RetainedEarnings"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_a80581da-e0cf-44b9-a6a9-b940332cd795" xlink:to="loc_ifrs-full_RetainedEarnings_d273e5da-9a8b-4e15-b021-61f662ed2ba6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapital_739556dd-3406-46c5-aafd-be53113e7223" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssuedCapital"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_a80581da-e0cf-44b9-a6a9-b940332cd795" xlink:to="loc_ifrs-full_IssuedCapital_739556dd-3406-46c5-aafd-be53113e7223" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilities_6b0ac4f3-de6f-4753-a861-8a37e2d99e80" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentPortionOfNoncurrentBondsIssued_71007b34-49e7-4652-9547-16402aaab9c7" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentPortionOfNoncurrentBondsIssued"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_6b0ac4f3-de6f-4753-a861-8a37e2d99e80" xlink:to="loc_ifrs-full_NoncurrentPortionOfNoncurrentBondsIssued_71007b34-49e7-4652-9547-16402aaab9c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_4be36ccd-276e-4217-9ea5-cef61589e1a6" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_6b0ac4f3-de6f-4753-a861-8a37e2d99e80" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_4be36ccd-276e-4217-9ea5-cef61589e1a6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pharming.com/role/StatementofchangesinequityStatement" xlink:type="simple" xlink:href="pharm-2024-12-31.xsd#StatementofchangesinequityStatement"/>
  <link:calculationLink xlink:role="http://www.pharming.com/role/StatementofchangesinequityStatement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome_d644c8ad-bb6b-4b45-9d26-6613b5b3668e" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_92e2cba6-42d4-4a6d-8730-413a7eb40eff" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_d644c8ad-bb6b-4b45-9d26-6613b5b3668e" xlink:to="loc_ifrs-full_ProfitLoss_92e2cba6-42d4-4a6d-8730-413a7eb40eff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_93e15b86-3adc-4ba1-98de-0ad50d2ad1cc" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_d644c8ad-bb6b-4b45-9d26-6613b5b3668e" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_93e15b86-3adc-4ba1-98de-0ad50d2ad1cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pharm_Reserves_7d4c1e4a-8d73-4554-b36a-51ac7b1fdadc" xlink:href="pharm-2024-12-31.xsd#pharm_Reserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_d644c8ad-bb6b-4b45-9d26-6613b5b3668e" xlink:to="loc_pharm_Reserves_7d4c1e4a-8d73-4554-b36a-51ac7b1fdadc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pharm_TotalTransactionsWithOwnersRecognizedDirectlyInEquity_3f14b79e-d249-465d-b981-8639331fec7d" xlink:href="pharm-2024-12-31.xsd#pharm_TotalTransactionsWithOwnersRecognizedDirectlyInEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransferToStatutoryReserve_e0714c81-f3bc-408f-9241-3a067605e0c0" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseThroughTransferToStatutoryReserve"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pharm_TotalTransactionsWithOwnersRecognizedDirectlyInEquity_3f14b79e-d249-465d-b981-8639331fec7d" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransferToStatutoryReserve_e0714c81-f3bc-408f-9241-3a067605e0c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pharm_OptionsExercisedAndLtipSharesIssued_ecc49f4f-c1fb-4b52-b97a-b817d1b8794e" xlink:href="pharm-2024-12-31.xsd#pharm_OptionsExercisedAndLtipSharesIssued"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pharm_TotalTransactionsWithOwnersRecognizedDirectlyInEquity_3f14b79e-d249-465d-b981-8639331fec7d" xlink:to="loc_pharm_OptionsExercisedAndLtipSharesIssued_ecc49f4f-c1fb-4b52-b97a-b817d1b8794e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_192f30b0-a5e4-4d94-8050-2f47eef0d328" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pharm_TotalTransactionsWithOwnersRecognizedDirectlyInEquity_3f14b79e-d249-465d-b981-8639331fec7d" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_192f30b0-a5e4-4d94-8050-2f47eef0d328" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions_369c3f5e-8fe0-40b3-8cac-3667db53ba49" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pharm_TotalTransactionsWithOwnersRecognizedDirectlyInEquity_3f14b79e-d249-465d-b981-8639331fec7d" xlink:to="loc_ifrs-full_DecreaseIncreaseThroughTaxOnSharebasedPaymentTransactions_369c3f5e-8fe0-40b3-8cac-3667db53ba49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_37931a8b-55e7-4c45-a552-30d1002847fd" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pharm_TotalTransactionsWithOwnersRecognizedDirectlyInEquity_3f14b79e-d249-465d-b981-8639331fec7d" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments_37931a8b-55e7-4c45-a552-30d1002847fd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.pharming.com/role/StatementofcashflowsindirectmethodStatement" xlink:type="simple" xlink:href="pharm-2024-12-31.xsd#StatementofcashflowsindirectmethodStatement"/>
  <link:calculationLink xlink:role="http://www.pharming.com/role/StatementofcashflowsindirectmethodStatement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_4b43b083-7d57-4a8d-a7cd-31fb59a6e1ff" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities_af2124ba-0cc4-4c28-ae43-7a20c76a5d16" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_4b43b083-7d57-4a8d-a7cd-31fb59a6e1ff" xlink:to="loc_ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities_af2124ba-0cc4-4c28-ae43-7a20c76a5d16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_613d87a6-f06d-4942-a708-6042e86c2772" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_4b43b083-7d57-4a8d-a7cd-31fb59a6e1ff" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_613d87a6-f06d-4942-a708-6042e86c2772" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities_03a62b71-da28-4448-bb34-2bbc69d628b9" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_4b43b083-7d57-4a8d-a7cd-31fb59a6e1ff" xlink:to="loc_ifrs-full_ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities_03a62b71-da28-4448-bb34-2bbc69d628b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities_3ff9e73a-44a7-43e2-a3b7-34e1d21cd793" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_4b43b083-7d57-4a8d-a7cd-31fb59a6e1ff" xlink:to="loc_ifrs-full_ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities_3ff9e73a-44a7-43e2-a3b7-34e1d21cd793" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_e7466c51-2586-431d-b125-89ae53349a1c" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_4b43b083-7d57-4a8d-a7cd-31fb59a6e1ff" xlink:to="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_e7466c51-2586-431d-b125-89ae53349a1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities_624b9d60-b090-4068-bb1c-8a9227f5e020" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_4b43b083-7d57-4a8d-a7cd-31fb59a6e1ff" xlink:to="loc_ifrs-full_ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities_624b9d60-b090-4068-bb1c-8a9227f5e020" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_67dade1f-2864-493f-b4ce-0d44aac97853" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_pharm_InterestPaidConvertibleBondsClassifiedAsFinancingActivities_fb215f38-2135-4b85-a38c-3232fa912b68" xlink:href="pharm-2024-12-31.xsd#pharm_InterestPaidConvertibleBondsClassifiedAsFinancingActivities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_67dade1f-2864-493f-b4ce-0d44aac97853" xlink:to="loc_pharm_InterestPaidConvertibleBondsClassifiedAsFinancingActivities_fb215f38-2135-4b85-a38c-3232fa912b68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_6ff6ebe8-aec1-4f30-8fa1-7603900eecd4" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_67dade1f-2864-493f-b4ce-0d44aac97853" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_6ff6ebe8-aec1-4f30-8fa1-7603900eecd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_4d3a5f61-f80a-40c2-ba9a-a0108a98f595" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromIssuingOtherEquityInstruments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_67dade1f-2864-493f-b4ce-0d44aac97853" xlink:to="loc_ifrs-full_ProceedsFromIssuingOtherEquityInstruments_4d3a5f61-f80a-40c2-ba9a-a0108a98f595" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures_b064b207-76dc-4070-b2c1-11ca4c7c7543" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RepaymentsOfBondsNotesAndDebentures"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_67dade1f-2864-493f-b4ce-0d44aac97853" xlink:to="loc_ifrs-full_RepaymentsOfBondsNotesAndDebentures_b064b207-76dc-4070-b2c1-11ca4c7c7543" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures_40d3fa50-1d56-4666-8bc7-f2e9bd0a8658" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_67dade1f-2864-493f-b4ce-0d44aac97853" xlink:to="loc_ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures_40d3fa50-1d56-4666-8bc7-f2e9bd0a8658" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pharm_InterestPaidLeaseLiabilitiesClassifiedAsFinancingActivities_414b2411-78ff-4ee4-9082-c407f83cf304" xlink:href="pharm-2024-12-31.xsd#pharm_InterestPaidLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_67dade1f-2864-493f-b4ce-0d44aac97853" xlink:to="loc_pharm_InterestPaidLeaseLiabilitiesClassifiedAsFinancingActivities_414b2411-78ff-4ee4-9082-c407f83cf304" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_bcdd0850-28e1-4c6e-9c04-ec52b9a8d89a" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForFinanceCosts_d1753ba4-43e3-4d70-9107-e88800a6581f" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForFinanceCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_bcdd0850-28e1-4c6e-9c04-ec52b9a8d89a" xlink:to="loc_ifrs-full_AdjustmentsForFinanceCosts_d1753ba4-43e3-4d70-9107-e88800a6581f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForFinanceIncome_bcb44b00-80a0-4f4b-a460-ac903d0593b9" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForFinanceIncome"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_bcdd0850-28e1-4c6e-9c04-ec52b9a8d89a" xlink:to="loc_ifrs-full_AdjustmentsForFinanceIncome_bcb44b00-80a0-4f4b-a460-ac903d0593b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_ed8b4209-81a7-42b0-a927-12bacf5e3d29" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_bcdd0850-28e1-4c6e-9c04-ec52b9a8d89a" xlink:to="loc_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss_ed8b4209-81a7-42b0-a927-12bacf5e3d29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_e14ceb66-9401-46a2-a847-899cc80adb52" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForFairValueGainsLosses"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_bcdd0850-28e1-4c6e-9c04-ec52b9a8d89a" xlink:to="loc_ifrs-full_AdjustmentsForFairValueGainsLosses_e14ceb66-9401-46a2-a847-899cc80adb52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_7fdadc8c-a535-4feb-8c57-d9a6c6c69846" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_bcdd0850-28e1-4c6e-9c04-ec52b9a8d89a" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_7fdadc8c-a535-4feb-8c57-d9a6c6c69846" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_9f71596e-7a75-4906-a523-13d3f0cf0964" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_bcdd0850-28e1-4c6e-9c04-ec52b9a8d89a" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_9f71596e-7a75-4906-a523-13d3f0cf0964" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForUndistributedProfitsOfAssociates_e5aa61ff-6ca3-4af4-a7a1-3acd3733f893" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForUndistributedProfitsOfAssociates"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_bcdd0850-28e1-4c6e-9c04-ec52b9a8d89a" xlink:to="loc_ifrs-full_AdjustmentsForUndistributedProfitsOfAssociates_e5aa61ff-6ca3-4af4-a7a1-3acd3733f893" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherAdjustmentsForNoncashItems_ce460f26-a45d-4536-9455-0d11124daff6" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherAdjustmentsForNoncashItems"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_bcdd0850-28e1-4c6e-9c04-ec52b9a8d89a" xlink:to="loc_ifrs-full_OtherAdjustmentsForNoncashItems_ce460f26-a45d-4536-9455-0d11124daff6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pharm_GainsOnDisposalsOfPriorityReviewVoucher_057e988d-00de-46cc-8c41-aef978be18a1" xlink:href="pharm-2024-12-31.xsd#pharm_GainsOnDisposalsOfPriorityReviewVoucher"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_bcdd0850-28e1-4c6e-9c04-ec52b9a8d89a" xlink:to="loc_pharm_GainsOnDisposalsOfPriorityReviewVoucher_057e988d-00de-46cc-8c41-aef978be18a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pharm_AdjustmentsForLossesGainsOnDisposalOfLeases_8330deed-f059-4ab3-bedb-95fa7d7f6d8a" xlink:href="pharm-2024-12-31.xsd#pharm_AdjustmentsForLossesGainsOnDisposalOfLeases"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_bcdd0850-28e1-4c6e-9c04-ec52b9a8d89a" xlink:to="loc_pharm_AdjustmentsForLossesGainsOnDisposalOfLeases_8330deed-f059-4ab3-bedb-95fa7d7f6d8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_0791339d-7479-4f77-baf7-345d9416f7ac" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseInWorkingCapital"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_38553898-3ca2-4286-8606-1c510d3a23e7" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_0791339d-7479-4f77-baf7-345d9416f7ac" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables_38553898-3ca2-4286-8606-1c510d3a23e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents_d0241bbe-0aa2-4c4e-b1ce-cadd5f628ba5" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_0791339d-7479-4f77-baf7-345d9416f7ac" xlink:to="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents_d0241bbe-0aa2-4c4e-b1ce-cadd5f628ba5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_6a7eddb6-ca45-4ee9-b234-1afafa732e99" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_0791339d-7479-4f77-baf7-345d9416f7ac" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_6a7eddb6-ca45-4ee9-b234-1afafa732e99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_d5758c04-b3e3-4b0e-892d-91cf29f8b463" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_0791339d-7479-4f77-baf7-345d9416f7ac" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_d5758c04-b3e3-4b0e-892d-91cf29f8b463" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_d49463ba-9dec-4fa9-a596-24c365d9c204" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_3275ea83-e14e-41ec-af0e-acb7fe710701" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseInWorkingCapital"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_d49463ba-9dec-4fa9-a596-24c365d9c204" xlink:to="loc_ifrs-full_IncreaseDecreaseInWorkingCapital_3275ea83-e14e-41ec-af0e-acb7fe710701" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_193717a0-104c-499d-9bb6-53bd490abdd4" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_d49463ba-9dec-4fa9-a596-24c365d9c204" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_193717a0-104c-499d-9bb6-53bd490abdd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_795e989e-4561-4482-8ca3-5c44b6eabf90" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_d49463ba-9dec-4fa9-a596-24c365d9c204" xlink:to="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_795e989e-4561-4482-8ca3-5c44b6eabf90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_f97fe297-379e-4504-baf4-c98a293fc299" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InterestReceivedClassifiedAsOperatingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_d49463ba-9dec-4fa9-a596-24c365d9c204" xlink:to="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_f97fe297-379e-4504-baf4-c98a293fc299" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_cd62bbe4-c451-406e-8051-ecf256d35e70" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_66284cbd-030d-4c67-bac0-26b7a30be0cd" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_cd62bbe4-c451-406e-8051-ecf256d35e70" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_66284cbd-030d-4c67-bac0-26b7a30be0cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_fa6a9ec9-184c-4ba6-b63f-851a12cce862" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_cd62bbe4-c451-406e-8051-ecf256d35e70" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_fa6a9ec9-184c-4ba6-b63f-851a12cce862" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_077a3f8a-e7cf-400d-9baf-59de59201330" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_cd62bbe4-c451-406e-8051-ecf256d35e70" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_077a3f8a-e7cf-400d-9baf-59de59201330" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
